Award
Delivery Order #SPE2DR26F49L0
Short-Term Delivery Order for Labetalol Tablets to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$183.38
Ceiling
$183.38
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26F49L0
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a specific shipment of Labetalol HCL 200 mg tablets, an essential medication used in healthcare. The order supports federal healthcare programs by ensuring the availability of crucial pharmaceutical products for patient treatment. The scope involves the procurement and timely delivery of the specified drug quantity within a very short timeframe. This award was issued under the parent contract SPE2DR25D3304, which covers broader pharmaceutical distribution services through a competitive, multi-year IDV. The delivery order reflects an operational tasking against this larger contract, with performance scheduled over a one-day period in early 2026 to meet immediate medical needs. The contract enhances the government’s capability to efficiently manage drug supplies while leveraging an established trusted vendor relationship.
Description
4571167049!LABETALOL HCL 200 MG TABLET 100S